Dexcom to Add Ambulatory Glucose Profile (AGP) to Dexcom CLARITY

EDINBURGH, Scotland, September 11, 2017

DexCom, Inc. (NASDAQ: DXCM), the leader in continuous glucose monitoring (CGM) for people with diabetes, announced today that it incorporated Ambulatory Glucose Profile (AGP) into its Dexcom CLARITY software for Europe. A web-based software, Dexcom CLARITY provides access to clinically relevant metrics and reports for data analyses and diabetes management planning.

     (Logo: http://mma.prnewswire.com/media/553571/Dexcom_Logo.jpg )
The Ambulatory Glucose Profile report, known as captūrAGP^®, was developed by the International Diabetes Center (IDC), with input from endocrinologists and clinicians who are experts in data management and interpretation.^[1],[2] AGP includes a summary of patient glucose data in three parts:

(1) statistical summary, (2) visual display, and (3) daily views. These components create a common platform for patients and clinicians to view glucose patterns and trends.

"Dexcom is pleased to partner with the IDC in implementing a standard report across all platforms - allowing physicians and health care professionals to compare information in a consistent format," said Kevin Sayer, President and Chief Executive Officer, Dexcom. "As the industry leader in continuous glucose monitoring, it is important that we align with industry recommendations and clinical societies to provide the tools and information needed to help clinicians improve clinic work flow while managing their patients' diabetes with glucose data and reporting."

Dexcom will be featuring the new updates to Dexcom CLARITY, including AGP, at the 53^rd Annual Meeting of the European Association for the Study of Diabetes (EASD). Dexcom CLARITY experts will be available to demo the software in our booth L03.

"I hope that utilising the AGP to standardise CGM metrics and the glucose profile display will help clinicians and patients together to formulate a personalised action plan to optimise glucose control," says Richard Bergenstal, MD, Endocrinologist and Executive Director of the International Diabetes Center, St Louis Park, MN.